Relationship between cell cycle and cancer development: Therapeutical approaches.

被引:3
作者
PeraltaZaragoza, O [1 ]
BahenaRoman, M [1 ]
DiazBenitez, CE [1 ]
MadridMarina, V [1 ]
机构
[1] INST NACL SALUD PUBL, CTR INVEST ENFERMEDADES INFECCIOSAS, AREA VIROL MOL, CUERNAVACA 62508, MORELOS, MEXICO
来源
SALUD PUBLICA DE MEXICO | 1997年 / 39卷 / 05期
关键词
cell cycle; gene expression regulation; antineoplastic agents; combined; Mexico;
D O I
10.1590/S0036-36341997000500008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Several genetic alterations occur during the transformation process from normal to tumor cells, that involve the loss of fidelity of processes as replication, reparation, and segregation of the genomic material. Although normal cells have defense mechanisms against cancer progression, in tumor cells different escape pathways are activated leading to tumor progression. Recent advances have permitted cancer research to focus on the identification of some of its etiological factors. The knowledge of cell cycle reveals a precise mechanism achieved by the coordinated interactions and functions of cyclin-dependent kinases, control checkpoint, and repair pathways. Furthermore, it has been demonstrated that this cordinated function can be abrogated by specific genetic changes. These findings suggest that the molecular mechanisms responsible for cellular transformation may help to identify potential targets to improve cancer therapies.
引用
收藏
页码:451 / 462
页数:12
相关论文
共 79 条
  • [21] Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells
    Hamada, K
    Sakaue, M
    Alemany, R
    Zhang, WW
    Horio, Y
    Roth, JA
    Mitchell, MF
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 63 (02) : 219 - 227
  • [22] A CELL-CYCLE-REGULATED INHIBITOR OF CYCLIN-DEPENDENT KINASES
    HENGST, L
    DULIC, V
    SLINGERLAND, JM
    LEES, E
    REED, SI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) : 5291 - 5295
  • [23] HISAO O, 1995, CANCER, V75, pS1454
  • [24] P53 MUTATIONS IN HUMAN CANCERS
    HOLLSTEIN, M
    SIDRANSKY, D
    VOGELSTEIN, B
    HARRIS, CC
    [J]. SCIENCE, 1991, 253 (5015) : 49 - 53
  • [25] HOOPER ML, 1994, J CELL SCI, P13
  • [26] DIVERSE EFFECTS OF BETA-TUBULIN MUTATIONS ON MICROTUBULE FORMATION AND FUNCTION
    HUFFAKER, TC
    THOMAS, JH
    BOTSTEIN, D
    [J]. JOURNAL OF CELL BIOLOGY, 1988, 106 (06) : 1997 - 2010
  • [27] A CELLULAR PROTEIN MEDIATES ASSOCIATION OF P53 WITH THE E6 ONCOPROTEIN OF HUMAN PAPILLOMAVIRUS TYPE-16 OR TYPE-18
    HUIBREGTSE, JM
    SCHEFFNER, M
    HOWLEY, PM
    [J]. EMBO JOURNAL, 1991, 10 (13) : 4129 - 4135
  • [28] A CELL-CYCLE REGULATOR POTENTIALLY INVOLVED IN GENESIS OF MANY TUMOR TYPES
    KAMB, A
    GRUIS, NA
    WEAVERFELDHAUS, J
    LIU, QY
    HARSHMAN, K
    TAVTIGIAN, SV
    STOCKERT, E
    DAY, RS
    JOHNSON, BE
    SKOLNICK, MH
    [J]. SCIENCE, 1994, 264 (5157) : 436 - 440
  • [29] KASHII T, 1995, ONCOLOGY-BASEL, V52, P219
  • [30] A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA
    KASTAN, MB
    ZHAN, QM
    ELDEIRY, WS
    CARRIER, F
    JACKS, T
    WALSH, WV
    PLUNKETT, BS
    VOGELSTEIN, B
    FORNACE, AJ
    [J]. CELL, 1992, 71 (04) : 587 - 597